OTC: EKTAF - Elekta AB (publ)

Yield per half year: -15.52%
Dividend yield: +0.03%
Sector: Healthcare

Share chart Elekta AB (publ)


About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

more details
It also provides Elekta Studio, an image guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; Geneva, an applicator for cervical cancer treatment; veterinary radiation therapy products; and Elekta Kaiku for personalized cancer care. In addition, the company offers stereotactic radiosurgery, such as Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for radiosurgeons; and Elekta Esprit. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета sek
Див.доход ао 0.0299
Дивиденд ао 0.1167
Сайт https://elekta.com
Цена ао 5.66
Change price per day: 0% (5.66)
Change price per week: -5.67% (6)
Change price per month: +4.04% (5.44)
Change price per 3 month: -4.07% (5.9)
Change price per half year: -15.52% (6.7)
Change price per year: -21.61% (7.22)
Change price per 3 year: -55.85% (12.82)
Change price per 5 year: -35.39% (8.76)
Change price per 10 year: 0% (5.66)
Change price per year to date: +0.177% (5.65)

Underestimation

Title Value Grade
P/S 1.74 8
P/BV 2.93 6
P/E 24.24 6
EV/EBITDA 10.97 7
Total: 6.13

Efficiency

Title Value Grade
ROA, % 4.23 1
ROE, % 12.7 4
Total: 3.83

Dividends

Title Value Grade
Div yield, % 0.0291 0.08
DSI 0.8571 8.57
Total: 3.3

Debt

Title Value Grade
Debt/EBITDA 2.21 6
Total: 4.8

Growth impulse

Title Value Grade
Yield Revenue, % 24.09 4
Yield Ebitda, % 2.18 1
Yield EPS, % 19.99 3
Total: 4.4



Head Job title Payment Year of birth
Dr. Laurent Leksell Founder & Chairman 1.64M 1952 (73 years)
Mr. Gustaf Salford President & CEO 14.62M 1977 (48 years)
Mr. Tobias Hagglov Chief Financial Officer N/A 1978 (47 years)
Mr. Jonas Bolander Executive VP of Group Functions, Secretary & General Counsel N/A 1966 (59 years)
Mr. Mattias Thorsson VP and Head of Corporate Communications & Public Affairs N/A
Ms. Anna Conneryd Lundgren Executive VP & Chief People Officer N/A 1985 (40 years)
Mr. John Lapré President of Brachy & Neuro Solutions N/A 1964 (61 year)
Mr. Maurits Wolleswinkel President of Linac & Software Solutions N/A 1971 (54 years)
Mr. Habib Nehme Chief Commercial Officer N/A 1964 (61 year)
Mr. Peter Nyquist Head of Investor Relations N/A 1965 (60 years)

Address: Sweden, Stockholm, Hagaplan 4 - open in Google maps, open in Yandex maps
Website: https://elekta.com